Thiogenesis Therapeutics, Corp. Share Price
Equities
TTI
CA88410L1022
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.66 CAD | -2.94% | -4.35% | -12.00% |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 30.94M 22.58M 1.89B |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 80.96% |
1 day | -2.94% | ||
1 week | -4.35% | ||
Current month | -5.71% | ||
1 month | -5.71% | ||
3 months | -17.50% | ||
6 months | -15.38% | ||
Current year | -12.00% |
Managers | Title | Age | Since |
---|---|---|---|
Patrice Rioux
FOU | Founder | 73 | 01/18/01 |
Brook Riggins
DFI | Director of Finance/CFO | 58 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Kim Tsuchimoto
BRD | Director/Board Member | 61 | 31/22/31 |
Chairman | 71 | 31/22/31 | |
Brook Riggins
DFI | Director of Finance/CFO | 58 | - |
Date | Price | Change | Volume |
---|---|---|---|
05/24/05 | 0.66 | -2.94% | 11 000 |
04/24/04 | 0.68 | +4.62% | 8,500 |
03/24/03 | 0.65 | -7.14% | 32,000 |
31/24/31 | 0.7 | +1.45% | 50,000 |
30/24/30 | 0.69 | -1.43% | 4,000 |
Delayed Quote Toronto S.E., June 05, 2024 at 10:56 pm IST
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-12.00% | 22.61M | |
+55.70% | 55.7B | |
+41.08% | 39.91B | |
-5.39% | 39.57B | |
-5.56% | 28.16B | |
+16.46% | 26.3B | |
-20.56% | 18.94B | |
+33.03% | 12.17B | |
+25.85% | 12.12B | |
+2.72% | 12.12B |
- Stock Market
- Equities
- TTI Stock